In partnership with Cybin, we are hosting a panel discussion titled “Psychedelics Landscape – What can we expect?” 

Psychedelics are showing promise in treating mental health conditions, but to ensure their use is not severely limited, legal and other obstacles will need to be navigated. This session will provide insights into the opportunities and challenges surrounding psychedelic medicines, with an expert panel to facilitate a discussion on the political, financial, IP and regulatory considerations on the road to commercial success.

Our expert panel includes:

  • Doug Drysdale, CEO, Cybin

  • Dr. Christopher Golden, Director - Healthcare & Life Sciences, Peel Hunt 

  • Mark Ferguson, Head of Reputation, Crisis, and Client Operations, Pinsent Masons


Who should attend?

This event is aimed at Life Sciences and Healthcare experts.


Event date

17:00 - 18:00 GMT

Pinsent Masons Video


Doug Drysdale

CEO at Cybin

Dr. Christopher Golden

Director - Healthcare & Life Sciences at Peel Hunt

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.